e-CancerCare Insurance explained: benefits, limits and the fine print
Etiqa's e-CancerCare pays a rising percentage of the sum insured as cancer progresses through three stages, bought directly with no intermediary. Here is what the disclosure sheet actually says.
e-CancerCare is Etiqa's single-condition cancer plan: it covers cancer only, at three defined stages, rather than the broader list of illnesses a typical critical illness plan bundles together. It is sold directly, with instant approval and no intermediary involved in the purchase. The figures below reflect Etiqa's own published product disclosure sheet as at the date it was issued, and can change — the disclosure sheet and policy contract, not this article, are what actually governs a claim.
What kind of plan this is
e-CancerCare is a pure protection, cancer-only insurance plan, structured to pay out in stages rather than as a single lump sum on any cancer diagnosis. It is not a broad multi-illness critical illness plan; it responds specifically to cancer, defined and staged as set out in the policy contract.
Key benefits as published
- Early stage cancer pays 30% of the sum insured, as a benefit payable once.
- Major cancer pays 100% of the sum insured, or 70% if the early stage benefit was already claimed.
- Advanced cancer pays 150% of the sum insured, or 120% if the early stage benefit was already claimed.
- Early stage coverage extends beyond the obvious cases, including carcinoma-in-situ and early-stage bladder, prostate and thyroid cancer, as well as early chronic lymphocytic leukemia.
- Sum insured of up to RM300,000.
- Instant approval, bought directly without going through an agent or broker.
How the staged payout actually works
The structure rewards buying the plan before any diagnosis, and it reduces future payouts once an earlier stage has already been claimed. An early stage claim pays 30% of the sum insured once, and that amount is deducted from what remains payable on a later major or advanced cancer claim — so a person who claims early stage, then later progresses to major cancer, receives 70% rather than the full 100%. The policy ends once the major cancer benefit has been paid, meaning the advanced cancer benefit is only available if major cancer has not already been claimed in full.
A claim requires the insured to survive 30 days from the date of diagnosis, a standard survival period feature across critical-illness style products, but confirm the exact wording in the policy contract rather than relying on the summary alone.
Where the fine print matters
A few details are not fully spelled out on the product page itself, and are worth confirming directly against the disclosure sheet or policy contract before buying:
- Entry age and coverage end age are not stated on the product page. The published summary does not give these figures, so check the current product disclosure sheet directly for the age limits that apply.
- The waiting period from the policy's start date is not detailed in the summary. Ask Etiqa or read the policy contract for how soon after the certificate begins a diagnosis becomes claimable.
- Rates differ by sex. Etiqa publishes separate rate tables for male and female applicants, so a quote should be checked against the table matching the applicant, not assumed to be a single flat rate.
- PIDM protection applies up to the standard limits. As with other insurance benefits issued in Malaysia, the benefits under this plan are protected under the Takaful and Insurance Benefits Protection System administered by PIDM, subject to the scheme's usual limits.
What a buyer should check in general, beyond this product
- Whether a single-condition cancer plan is what you need, or whether a broader multi-illness critical illness plan would cover more scenarios for a comparable premium.
- How the staged payout compares with a plan that pays a full lump sum on first diagnosis, since the trade-off here is a lower early payout in exchange for potentially covering three separate stages over time.
- Whether the sum insured of up to RM300,000 is adequate against your own income replacement and treatment cost needs, compared with other critical illness products in the market.
- Entry age, coverage end age and waiting period, confirmed directly with Etiqa since these were not stated in the summary reviewed here.
None of this is a comment on whether e-CancerCare is the best or cheapest cancer plan for your situation. Compare it against other critical illness products at compare/my/critical-illness, or check your existing cover with our coverage gap check.
Talk to an advisor
A staged cancer-only payout structure works differently from a standard lump-sum critical illness plan, and the entry age, waiting period and rate table details are worth confirming directly before buying. A licensed advisor can check the current terms with Etiqa and compare this plan against a broader critical illness alternative. Find one through our advisor directory, or ask our assistant to walk through how the staged payout would apply to your own situation.
Sources
This content is educational information from a licensed advisor, not financial advice. Product details vary by insurer — verify specifics with an advisor.
